Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study

Extended-release osmotic extended-release oral delivery system (OROS) hydromorphone is a strong synthetic opioid designed to maintain a constant blood concentration by once daily dosing. The objective of this observational study was to investigate the clinical usefulness of OROS hydromorphone in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Cheol Kyu, Kang, Hyun-Wook, Oh, In-Jae, Kim, Young-Chul, Kim, Yeo-Kyeoung, Na, Kook-Joo, Ahn, Sung-Ja, Kim, Tae Ok, Choi, Young Jin, Song, Geun Am, Lee, Min Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102854/
https://www.ncbi.nlm.nih.gov/pubmed/27822929
http://dx.doi.org/10.3346/jkms.2016.31.12.1914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102854/
https://www.ncbi.nlm.nih.gov/pubmed/27822929
http://dx.doi.org/10.3346/jkms.2016.31.12.1914

Ejemplares similares